Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, BHVN, KURA, ACLX, QQQ, and represent 29.72% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$235M), QQQ (+$87M), ARQT (+$67M), VZ (+$50M), CI (+$48M), ARGX (+$47M), RARE (+$47M), GS (+$46M), TSM (+$45M), T (+$42M).
- Started 34 new stock positions in IMTX, CRL, GEHC, HUM, TSM, T, RMD, MS, VLTO, Arrivent Biopharma.
- Reduced shares in these 10 stocks: Horizon Therapeutics (-$91M), ACLX (-$91M), AMD (-$64M), MSFT (-$58M), RPRX (-$56M), META (-$52M), AMZN (-$47M), WYNN (-$43M), INSM (-$39M), NVDA (-$39M).
- Sold out of its positions in AGIO, ANAB, AZN, BNTX, COF, IDXX, INCY, LVS, LLY, NVDA. NRIX, Opy Acquisition Corp I, RH, SANA, SRPT, UTHR, WFC, WYNN, Horizon Therapeutics, ALVO.
- Suvretta Capital Management was a net buyer of stock by $154M.
- Suvretta Capital Management has $2.7B in assets under management (AUM), dropping by 45.50%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 101 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.7 | $235M | NEW | 450k | 523.07 |
|
| Biohaven (BHVN) | 8.1 | $219M | 4.0M | 54.69 |
|
|
| Kura Oncology (KURA) | 5.6 | $151M | -3% | 7.1M | 21.33 |
|
| Arcellx Common Stock (ACLX) | 4.0 | $109M | -45% | 1.6M | 69.55 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 3.2 | $87M | NEW | 195k | 444.01 |
|
| Meta Platforms Cl A (META) | 3.1 | $84M | -38% | 174k | 485.58 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.9 | $78M | +146% | 1.7M | 46.69 |
|
| Arcutis Biotherapeutics (ARQT) | 2.9 | $78M | +593% | 7.9M | 9.91 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.9 | $78M | +7% | 3.8M | 20.67 |
|
| 89bio (ETNB) | 2.7 | $73M | +133% | 6.3M | 11.64 |
|
| Royalty Pharma Shs Class A (RPRX) | 2.5 | $68M | -45% | 2.3M | 30.37 |
|
| Intra Cellular Therapies (ITCI) | 2.5 | $66M | -29% | 959k | 69.20 |
|
| Amazon (AMZN) | 2.4 | $64M | -42% | 357k | 180.38 |
|
| Advanced Micro Devices (AMD) | 2.3 | $62M | -50% | 342k | 180.49 |
|
| Insmed Com Par $.01 (INSM) | 2.0 | $55M | -41% | 2.0M | 27.13 |
|
| Cigna Corp (CI) | 1.8 | $50M | +3328% | 137k | 363.19 |
|
| Kalvista Pharmaceuticals (KALV) | 1.8 | $50M | +73% | 4.2M | 11.86 |
|
| Verizon Communications (VZ) | 1.8 | $50M | NEW | 1.2M | 41.96 |
|
| Argenx Se Sponsored Adr (ARGX) | 1.8 | $48M | +4253% | 122k | 393.72 |
|
| Marinus Pharmaceuticals Com New (MRNS) | 1.7 | $46M | 5.1M | 9.04 |
|
|
| Goldman Sachs (GS) | 1.7 | $46M | NEW | 110k | 417.69 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.7 | $45M | NEW | 329k | 136.05 |
|
| At&t (T) | 1.6 | $42M | NEW | 2.4M | 17.60 |
|
| Apollo Global Mgmt (APO) | 1.5 | $42M | +93% | 371k | 112.45 |
|
| Ferguson SHS (FERG) | 1.4 | $37M | NEW | 169k | 218.43 |
|
| General Electric Com New (GE) | 1.4 | $36M | -40% | 207k | 175.53 |
|
| Coca-Cola Company (KO) | 1.2 | $33M | NEW | 547k | 61.18 |
|
| Microsoft Corporation (MSFT) | 1.2 | $33M | -63% | 79k | 420.72 |
|
| Sutro Biopharma (STRO) | 1.2 | $33M | 5.8M | 5.65 |
|
|
| McKesson Corporation (MCK) | 1.1 | $30M | +50% | 57k | 536.85 |
|
| Apple (AAPL) | 1.1 | $30M | NEW | 177k | 171.48 |
|
| CRH Ord (CRH) | 1.1 | $29M | NEW | 336k | 86.26 |
|
| Arrivent Biopharma | 1.0 | $28M | NEW | 1.6M | 17.86 |
|
| Fulcrum Therapeutics (FULC) | 1.0 | $27M | -50% | 2.8M | 9.44 |
|
| Anthem (ELV) | 1.0 | $26M | +1591% | 51k | 518.54 |
|
| Oracle Corporation (ORCL) | 0.9 | $25M | -22% | 197k | 125.61 |
|
| Chipotle Mexican Grill (CMG) | 0.9 | $23M | -60% | 8.0k | 2906.77 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.8 | $23M | -9% | 915k | 24.90 |
|
| Pepgen (PEPG) | 0.8 | $22M | +212% | 1.5M | 14.70 |
|
| Boston Scientific Corporation (BSX) | 0.8 | $21M | -14% | 303k | 68.49 |
|
| Fate Therapeutics (FATE) | 0.7 | $19M | NEW | 2.6M | 7.34 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.7 | $18M | +60% | 957k | 18.88 |
|
| Hilton Worldwide Holdings (HLT) | 0.6 | $17M | -31% | 79k | 213.31 |
|
| salesforce (CRM) | 0.6 | $17M | NEW | 55k | 301.18 |
|
| Starbucks Corporation (SBUX) | 0.6 | $16M | NEW | 173k | 91.39 |
|
| Johnson & Johnson (JNJ) | 0.5 | $14M | 90k | 158.19 |
|
|
| Global Payments (GPN) | 0.5 | $14M | -62% | 106k | 133.66 |
|
| Pinterest Cl A (PINS) | 0.5 | $14M | NEW | 396k | 34.67 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.4 | $12M | -50% | 3.7M | 3.30 |
|
| Sanofi Sponsored Adr (SNY) | 0.4 | $10M | +81% | 211k | 48.60 |
|
| Immatics SHS (IMTX) | 0.4 | $9.9M | NEW | 947k | 10.51 |
|
| Terns Pharmaceuticals (TERN) | 0.3 | $8.9M | -77% | 1.4M | 6.56 |
|
| Inflarx Nv (IFRX) | 0.3 | $8.8M | 5.7M | 1.54 |
|
|
| Elanco Animal Health (ELAN) | 0.3 | $8.3M | -5% | 507k | 16.28 |
|
| Revance Therapeutics (RVNC) | 0.3 | $7.9M | NEW | 1.6M | 4.92 |
|
| UnitedHealth (UNH) | 0.3 | $7.5M | -44% | 15k | 494.70 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $7.3M | 2.9M | 2.57 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.3 | $6.8M | NEW | 75k | 90.91 |
|
| Korro Bio (KRRO) | 0.2 | $6.6M | NEW | 74k | 90.00 |
|
| Kezar Life Sciences (KZR) | 0.2 | $6.5M | 7.2M | 0.90 |
|
|
| Prokidney Corp Class A Ord Shs (PROK) | 0.2 | $6.3M | 3.9M | 1.64 |
|
|
| Spyre Therapeutics Com New (SYRE) | 0.2 | $6.2M | 162k | 37.93 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $4.9M | NEW | 33k | 149.45 |
|
| Thermo Fisher Scientific (TMO) | 0.2 | $4.2M | 7.3k | 581.21 |
|
|
| Danaher Corporation (DHR) | 0.2 | $4.1M | 16k | 249.72 |
|
|
| Abbott Laboratories (ABT) | 0.1 | $3.8M | +62% | 34k | 113.66 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.1 | $3.8M | -46% | 268k | 14.11 |
|
| Gilead Sciences (GILD) | 0.1 | $3.7M | +123% | 51k | 73.25 |
|
| Kenvue (KVUE) | 0.1 | $3.7M | 172k | 21.46 |
|
|
| AmerisourceBergen (COR) | 0.1 | $3.0M | 13k | 242.99 |
|
|
| Tourmaline Bio (TRML) | 0.1 | $2.9M | NEW | 125k | 22.90 |
|
| Mettler-Toledo International (MTD) | 0.1 | $2.6M | NEW | 2.0k | 1331.29 |
|
| Natera (NTRA) | 0.1 | $2.2M | -52% | 25k | 91.46 |
|
| Cogent Biosciences (COGT) | 0.1 | $2.1M | -89% | 316k | 6.72 |
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.1M | +69% | 5.2k | 399.09 |
|
| Avantor (AVTR) | 0.1 | $1.8M | +87% | 72k | 25.57 |
|
| Iqvia Holdings (IQV) | 0.1 | $1.8M | 7.2k | 252.89 |
|
|
| Molecular Partners Ads (MOLN) | 0.1 | $1.7M | 400k | 4.20 |
|
|
| Stryker Corporation (SYK) | 0.1 | $1.6M | 4.4k | 357.87 |
|
|
| Medtronic SHS (MDT) | 0.1 | $1.5M | 18k | 87.15 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 0.1 | $1.5M | 47k | 32.20 |
|
|
| CVS Caremark Corporation (CVS) | 0.1 | $1.4M | 17k | 79.76 |
|
|
| Illumina (ILMN) | 0.0 | $1.2M | 8.7k | 137.32 |
|
|
| Akili Common Stock (AKLI) | 0.0 | $1.1M | 3.8M | 0.29 |
|
|
| Waters Corporation (WAT) | 0.0 | $1.1M | 3.2k | 344.23 |
|
|
| Benitec Biopharma Com New (BNTC) | 0.0 | $1.1M | 204k | 5.25 |
|
|
| Hca Holdings (HCA) | 0.0 | $1.1M | NEW | 3.2k | 333.53 |
|
| Edwards Lifesciences (EW) | 0.0 | $1.1M | NEW | 11k | 95.56 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $882k | -71% | 31k | 28.93 |
|
| Dex (DXCM) | 0.0 | $816k | 5.9k | 138.70 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $726k | 5.0k | 145.51 |
|
|
| Morgan Stanley Com New (MS) | 0.0 | $720k | NEW | 7.6k | 94.16 |
|
| Humana (HUM) | 0.0 | $676k | NEW | 2.0k | 346.72 |
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $485k | NEW | 5.5k | 88.66 |
|
| ResMed (RMD) | 0.0 | $473k | NEW | 2.4k | 198.03 |
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $468k | NEW | 11k | 43.35 |
|
| Zimmer Holdings (ZBH) | 0.0 | $430k | NEW | 3.3k | 131.98 |
|
| Align Technology (ALGN) | 0.0 | $361k | NEW | 1.1k | 327.92 |
|
| Steris Shs Usd (STE) | 0.0 | $344k | NEW | 1.5k | 224.82 |
|
| Baxter International (BAX) | 0.0 | $341k | NEW | 8.0k | 42.74 |
|
| Charles River Laboratories (CRL) | 0.0 | $274k | NEW | 1.0k | 270.95 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022
- Suvretta Capital Management 2021 Q3 restated filed Nov. 16, 2021
- Suvretta Capital Management 2021 Q3 filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q3 amended filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q2 filed Aug. 16, 2021
- Suvretta Capital Management 2021 Q1 filed May 17, 2021
- Suvretta Capital Management 2020 Q4 filed Feb. 16, 2021
- Suvretta Capital Management 2020 Q3 filed Nov. 16, 2020